论文信息 - A Phase II Study of Intravenous Exatecan Administered Daily for 5 Days, Every 3 Weeks to Patients With Biliary Tract Cancers - 字舞流文

A Phase II Study of Intravenous Exatecan Administered Daily for 5 Days, Every 3 Weeks to Patients With Biliary Tract Cancers

G. Abou-Alfa | G. Schwartz | Sunil Sharma | E. Rowinsky | D. Kelsen | C. Becerra | S. Eckhardt | E. O’Reilly | Y. Patt | K. Feit | R. D. De Jager | E. Siegel